White Plains Hospital
White Plains, New York 10601
10 studies enrolling now · 28 studies all time
What they study most
Acute Myeloid Leukemia, Adenoma, Advanced Breast Cancer, Alopecia, Atrial Fibrillation, BRCA 1/2, Breast Cancer, Breast Neoplasms, Cancer, Chemotherapy-induced Alopecia, Chronic Lymphocytic Leukemia (CLL), Chronic Myelomonocytic Leukemia
Studies at this site
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) — Recruiting now
- Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
- Pancreatic Cancer Early Detection Consortium — Recruiting now
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) — Recruiting now
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation — Recruiting now
- GEMINI-NSCLC: NSCLC Biomarker Study — Recruiting now
- Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML — Recruiting now
- PF-07104091 as a Single Agent and in Combination Therapy — Running, not enrolling
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
- Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling
- Prevention of Colorectal Cancer Through Multiomics Blood Testing — Completed
- A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
- The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening — Completed
- Phase 2 Study of DKN-01 in Colorectal Cancer — Completed
- A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed
- Palbociclib in Real World Practice — Completed
- Pancreatic Cancer Early Detection Program — Status unconfirmed
- Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors — Stopped early
- A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads — Withdrawn before enrolling
- Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 — Completed
- informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
- A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer — Stopped early
- A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
- Effectiveness of the Adding High Fidelity Simulation to the Bleeding Control Course in Regards to Proper Tourniquet Placement Amongst School Personnel — Completed
- A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment — Status unconfirmed